ARVN | ArvinasNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$7.09
-$0.43 (-5.72%)

Arvinas (ARVN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat below the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $7.09 vs 50 $8.02 / 200 $9.64
Projection
No cross projected
Test
No active test
Last cross
Death cross 21 May 2026 ยท projected 28 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $7.86 vs 50 $10.04 / 200 $19.92
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 16 Jan 2023 ยท projected 28 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $6.98 vs 50 $7.43 / 200 $8.20
Projection
No cross projected
Test
No active test
Last cross
Death cross 2 Oct 2026 ยท projected 21 bars out

Cross history

20
crosses on record since 2020
9 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Oct 2026Death4-hour21 bars outNot tested
1 Sep 2026Golden4-hour29 bars out1 bar cross test
21 May 2026Death steepdaily28 bars outNot tested
1 Apr 2026Death4-hour21 bars outNot tested
18 Nov 2025Golden moderatedaily28 bars outNot tested

About ARVN

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.